These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15028614)

  • 1. In vivo estimation of imidazoline(2) binding site turnover.
    Paterson LM; Robinson ES; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():367-70. PubMed ID: 15028614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
    Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
    Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between imidazoline(2) sites and monoamine oxidase.
    Paterson LM; Tyacke RJ; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():353-6. PubMed ID: 15028610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain.
    Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
    Neuropharmacology; 2002 Jul; 43(1):75-83. PubMed ID: 12213261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.
    Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES
    J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
    King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites.
    MacInnes N; Handley SL
    Eur J Pharmacol; 2001 Oct; 428(2):221-5. PubMed ID: 11675039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
    Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brain.
    Robinson ES; Tyacke RJ; Nutt DJ; Hudson AL
    Eur J Pharmacol; 2002 Aug; 450(1):55-60. PubMed ID: 12176109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.
    Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A
    Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A; Todd KG; Baker GB
    Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.
    Steinberg MI; Wiest SA; Pickard RT; Chen K; Shih JC
    Ann N Y Acad Sci; 1999 Jun; 881():193-8. PubMed ID: 10415915
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
    Raddatz R; Lanier SM
    Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.
    MacInnes N; Handley SL
    Eur J Pharmacol; 2005 Jun; 516(2):139-44. PubMed ID: 15925361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR; Gundlach AL; Louis WJ
    Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of the I(2)-alkylating agent BU99006 on the immunodensity of imidazoline receptor proteins in the mouse brain.
    Garcia-Sevilla JA; Ferrer-Alcon M
    Ann N Y Acad Sci; 2003 Dec; 1009():323-31. PubMed ID: 15028606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
    Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
    J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.
    MacInnes N; Handley SL
    Br J Pharmacol; 2002 Mar; 135(5):1227-34. PubMed ID: 11877331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.